The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
- PMID: 22525486
- DOI: 10.1038/mp.2012.33
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
Abstract
In some patients with major depressive disorder (MDD), individual illness characteristics appear consistent with those of a neuroprogressive illness. Features of neuroprogression include poorer symptomatic, treatment and functional outcomes in patients with earlier disease onset and increased number and length of depressive episodes. In such patients, longer and more frequent depressive episodes appear to increase vulnerability for further episodes, precipitating an accelerating and progressive illness course leading to functional decline. Evidence from clinical, biochemical and neuroimaging studies appear to support this model and are informing novel therapeutic approaches. This paper reviews current knowledge of the neuroprogressive processes that may occur in MDD, including structural brain consequences and potential molecular mechanisms including the role of neurotransmitter systems, inflammatory, oxidative and nitrosative stress pathways, neurotrophins and regulation of neurogenesis, cortisol and the hypothalamic-pituitary-adrenal axis modulation, mitochondrial dysfunction and epigenetic and dietary influences. Evidence-based novel treatments informed by this knowledge are discussed.
Similar articles
-
The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.Biol Psychiatry. 2019 Mar 15;85(6):443-453. doi: 10.1016/j.biopsych.2018.09.031. Epub 2018 Oct 10. Biol Psychiatry. 2019. PMID: 30470559 Free PMC article. Review.
-
The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence.Neurosci Biobehav Rev. 2013 Sep;37(8):1336-45. doi: 10.1016/j.neubiorev.2013.04.014. Epub 2013 May 6. Neurosci Biobehav Rev. 2013. PMID: 23660457 Review.
-
Putative neuroprotective agents in neuropsychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:135-45. doi: 10.1016/j.pnpbp.2012.11.007. Epub 2012 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23178231 Review.
-
[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24. Encephale. 2012. PMID: 23062450 Review. French.
-
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.Neurosci Biobehav Rev. 2011 Jan;35(3):804-17. doi: 10.1016/j.neubiorev.2010.10.001. Epub 2010 Oct 8. Neurosci Biobehav Rev. 2011. PMID: 20934453 Review.
Cited by
-
Agomelatine prevented depression in the chronic restraint stress model through enhanced catalase activity and halted oxidative stress.PLoS One. 2024 Feb 9;19(2):e0289248. doi: 10.1371/journal.pone.0289248. eCollection 2024. PLoS One. 2024. PMID: 38335199 Free PMC article.
-
Support from parents, teachers, and peers and the moderation of subjective and objective stress of secondary school student.Sci Rep. 2024 Jan 12;14(1):1161. doi: 10.1038/s41598-024-51802-4. Sci Rep. 2024. PMID: 38216714 Free PMC article.
-
24S-Hydroxycholesterol in Neuropsychiatric Diseases: Schizophrenia, Autism Spectrum Disorder, and Bipolar Disorder.Adv Exp Med Biol. 2024;1440:293-304. doi: 10.1007/978-3-031-43883-7_15. Adv Exp Med Biol. 2024. PMID: 38036886
-
Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USA.J Comp Eff Res. 2024 Jan;13(1):e230091. doi: 10.57264/cer-2023-0091. Epub 2023 Nov 21. J Comp Eff Res. 2024. PMID: 37987716 Free PMC article.
-
Neurobiological mechanisms of ECT and TMS treatment in depression: study protocol of a multimodal magnetic resonance investigation.BMC Psychiatry. 2023 Oct 30;23(1):791. doi: 10.1186/s12888-023-05239-0. BMC Psychiatry. 2023. PMID: 37904091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
